Memorial Sloan Kettering Cancer Center researchers assessed patient satisfaction and preferences for telemedicine, finding that 45% of people with cancer preferred telemedicine, while 34% preferred office visits and 21% had no preference.
FDA has initiated the approval of leucovorin calcium tablets, rushing them to market as part of a push from the Trump administration to identify potential treatments for autism spectrum disorder.
